Published in Cell Biochem Funct on July 19, 2011
Construction of a computable network model for DNA damage, autophagy, cell death, and senescence. Bioinform Biol Insights (2013) 1.08
Cancer prevention with promising natural products: mechanisms of action and molecular targets. Anticancer Agents Med Chem (2012) 1.01
Infection of Primary Bovine Macrophages with Mycobacterium avium Subspecies paratuberculosis Suppresses Host Cell Apoptosis. Front Microbiol (2012) 0.98
Integrin/Fak/Src-mediated regulation of cell survival and anoikis in human intestinal epithelial crypt cells: selective engagement and roles of PI3-K isoform complexes. Apoptosis (2012) 0.97
Local caspase activation interacts with Slit-Robo signaling to restrict axonal arborization. J Cell Biol (2013) 0.96
Beyond annexin V: fluorescence response of cellular membranes to apoptosis. Cytotechnology (2012) 0.96
The STAT5b Pathway Defect and Autoimmunity. Front Immunol (2012) 0.94
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours. Br J Cancer (2011) 0.88
Autophagy in Apicomplexa: a life sustaining death mechanism? Trends Parasitol (2012) 0.87
Longitudinal label-free tracking of cell death dynamics in living engineered human skin tissue with a multimodal microscope. Biomed Opt Express (2014) 0.87
Arginine dependence of tumor cells: targeting a chink in cancer's armor. Oncogene (2016) 0.86
P2X7 receptor activation induces inflammatory responses in salivary gland epithelium. Am J Physiol Cell Physiol (2012) 0.86
Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis. J Cancer Res Clin Oncol (2013) 0.86
Untangling the Roles of Anti-Apoptosis in Regulating Programmed Cell Death using Humanized Yeast Cells. Front Oncol (2012) 0.85
Anti-Proliferative Activities and Apoptosis Induction by Triterpenes Derived from Eriobotrya japonica in Human Leukemia Cell Lines. Int J Mol Sci (2013) 0.85
Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis. Mar Drugs (2012) 0.85
Suppression of anoikis in human intestinal epithelial cells: differentiation state-selective roles of α2β1, α3β1, α5β1, and α6β4 integrins. BMC Cell Biol (2013) 0.81
Cellular senescence and autophagy of myoepithelial cells are involved in the progression of in situ areas of carcinoma ex-pleomorphic adenoma to invasive carcinoma. An in vitro model. J Cell Commun Signal (2015) 0.81
Cadmium induces liver cell apoptosis through caspase-3A activation in purse red common carp (Cyprinus carpio). PLoS One (2013) 0.80
Boolean network-based model of the Bcl-2 family mediated MOMP regulation. Theor Biol Med Model (2013) 0.79
The molecular mechanisms between autophagy and apoptosis: potential role in central nervous system disorders. Cell Mol Neurobiol (2014) 0.79
A voltage dependent non-inactivating Na+ channel activated during apoptosis in Xenopus oocytes. PLoS One (2014) 0.78
Kayeassamin A Isolated from the Flower of Mammea siamensis Triggers Apoptosis by Activating Caspase-3/-8 in HL-60 Human Leukemia Cells. Pharmacognosy Res (2016) 0.77
Effects of tetracycline on developmental toxicity and molecular responses in zebrafish (Danio rerio) embryos. Ecotoxicology (2015) 0.77
A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes. PLoS One (2013) 0.76
X/XO or H2O2 induced IPEC-J2 cell as a new in vitro model for studying apoptosis in post-weaning piglets. Cytotechnology (2014) 0.76
FK506-binding protein 5 inhibits proliferation and stimulates apoptosis of glioma cells. Arch Med Sci (2015) 0.76
Whole venom of Loxosceles similis activates caspases-3, -6, -7, and -9 in human primary skin fibroblasts. Toxicon (2014) 0.75
The mathematical model of the Bcl-2 family mediated MOMP regulation can perform a non-trivial pattern recognition. PLoS One (2013) 0.75
Auraptene, a Major Compound of Supercritical Fluid Extract of Phalsak (Citrus Hassaku Hort ex Tanaka), Induces Apoptosis through the Suppression of mTOR Pathways in Human Gastric Cancer SNU-1 Cells. Evid Based Complement Alternat Med (2015) 0.75
Developmental Neurotoxicity of Methamidophos in the Embryo-Larval Stages of Zebrafish. Int J Environ Res Public Health (2016) 0.75
Inhibitory effect of Embelin on human acute T cell lymphoma Jurkat cells through activation of the apoptotic pathway. Oncol Lett (2015) 0.75
Pelargonium quercetorum Agnew induces apoptosis without PARP or cytokeratin 18 cleavage in non-small cell lung cancer cell lines. Oncol Lett (2016) 0.75
Molecular basis for the interplay of apoptosis and proliferation mediated by Bcl-xL:Bim interactions in pancreatic cancer cells. Biochem Biophys Res Commun (2012) 0.75
Expression of bcl-2 and p53 in bovine cutaneous fibropapillomas. Infect Agent Cancer (2015) 0.75
Apoptotic Bax at Oxidatively Stressed Mitochondrial Membranes: Lipid Dynamics and Permeabilization. Biophys J (2017) 0.75
Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism (2010) 1.62
Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments. Biomark Med (2010) 1.41
Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract (2008) 1.08
Predictive value of the modified Early Warning Score in a Turkish emergency department. Eur J Emerg Med (2008) 1.01
Combination of fenretinide and indole-3-carbinol results in synergistic cytotoxic activity inducing apoptosis against human breast cancer cells in vitro. Anticancer Drugs (2013) 0.96
Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention? Clin Biochem (2008) 0.95
Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. J Med Food (2010) 0.94
Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis. Arch Med Res (2009) 0.94
Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease. Clin Biochem (2012) 0.93
Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease. Metab Syndr Relat Disord (2011) 0.92
The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy. Eur Arch Otorhinolaryngol (2011) 0.88
Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine (2012) 0.88
sFas levels increase in response to cisplatin-based chemotherapy in lung cancer patients. Cell Biochem Funct (2010) 0.87
Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels. Hepatology (2009) 0.86
Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology. Eur J Gastroenterol Hepatol (2012) 0.84
Liver disease and malnutrition. Best Pract Res Clin Gastroenterol (2013) 0.83
Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol (2007) 0.82
Risk factors for low back pain and its relation with pain related disability and depression in a Turkish sample. Turk Neurosurg (2009) 0.82
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Arch Med Res (2008) 0.82
Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis. Eur J Gastroenterol Hepatol (2010) 0.81
Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients. Med Sci Monit (2009) 0.81
Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease. Acta Cardiol (2008) 0.81
Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B. Clin Chim Acta (2010) 0.81
Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients. World J Gastroenterol (2007) 0.81
Nonalcoholic fatty liver disease: a nutritional approach. Metab Syndr Relat Disord (2012) 0.81
Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Dis Markers (2012) 0.80
The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease. Clin Chim Acta (2007) 0.80
Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy. Am J Nephrol (2011) 0.80
A "biomarker biopsy" for the diagnosis of NASH: promises from CK-18 fragments. Obes Surg (2008) 0.79
Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue. Hepatology (2009) 0.78
Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter. Eur J Gastroenterol Hepatol (2016) 0.78
A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. Scand J Gastroenterol (2014) 0.78
Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patients. Metabolism (2009) 0.78
Proteomic study of the microdissected aortic media in human thoracic aortic aneurysms. J Proteome Res (2014) 0.78
Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Scand J Gastroenterol (2009) 0.77
Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations? World J Gastroenterol (2009) 0.77
Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol (2015) 0.77
Can enhanced autophagy be associated with human longevity? Serum levels of the autophagy biomarker beclin-1 are increased in healthy centenarians. Rejuvenation Res (2014) 0.77
Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C. J Gastrointestin Liver Dis (2009) 0.77
Circulating vaspin and its relationship with insulin sensitivity, adiponectin and liver histology in subjects with non-alcoholic steatohepatitis. Scand J Gastroenterol (2011) 0.77
The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond. Hepatology (2009) 0.77
Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol (2015) 0.76
Small arterial elasticity predicts the extent of coronary artery disease: Relationship with serum uric acid. Atherosclerosis (2008) 0.76
Psychopathology in the context of obesity: the adiponectin hypothesis. Med Hypotheses (2007) 0.76
Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease. Hepatogastroenterology (2012) 0.76
The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts. J Gastroenterol (2010) 0.76
Biochemical and proteomic analysis of a potential anticancer agent: Palladium(II) Saccharinate complex of terpyridine acting through double strand break formation. J Proteome Res (2014) 0.76
Evaluation of apoptotic molecular pathways for smooth muscle cells isolated from thoracic aortic aneurysms in response to oxidized sterols. Mol Biol Rep (2014) 0.76
Folic Acid and vitamin B12 supplementation improves coronary flow reserve in elderly subjects with vitamin B12 deficiency. Arch Med Res (2010) 0.76
Metformin, hepatitis C, and insulin resistance: sufficient evidence? Hepatology (2009) 0.76
Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Am J Reprod Immunol (2009) 0.75
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels. Scand J Gastroenterol (2014) 0.75
Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease. Clin Biochem (2008) 0.75
Commentary on "Cytokeratin 18, a Marker of Cell Death, is Increased in Children With Suspected Nonalcoholic Fatty Liver Disease". J Pediatr Gastroenterol Nutr (2009) 0.75
Multimarker strategies for detecting NASH and NASH-related fibrosis: promises and caveats. Obes Surg (2011) 0.75
Liver enzymes and cardiovascular outcomes: a new research agenda. Hepatology (2010) 0.75
Unconjugated hyperbilirubinemia and liver histology in patients with non-alcoholic fatty liver disease. Clin Biochem (2012) 0.75
Molecular signatures of nonalcoholic fatty liver disease: the present and future. Hepatology (2010) 0.75
Is M65 really better than M30 as a biomarker of hepatic fibrosis? Hepatology (2012) 0.75
Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease. Hepatology (2010) 0.75
Coronary artery anomalies in patients with syndrome X. Anadolu Kardiyol Derg (2009) 0.75
Chemerin as a marker of subclinical cardiac involvement in psoriatic patients. Cardiol J (2017) 0.75
Concomitant colitis in a patient with Behcet's disease. J Gastrointestin Liver Dis (2008) 0.75
A palladium(II)-saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft model. Anticancer Drugs (2017) 0.75
The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study. Eur J Gastroenterol Hepatol (2017) 0.75
Acute myocardial infarction, ischemic cerebrovascular disease and variceal bleeding due to portal vein thrombosis in a patient with hereditary thrombophilia. Blood Coagul Fibrinolysis (2008) 0.75
Evaluation of the molecular mechanisms of a palladium(II) saccharinate complex with terpyridine as an anticancer agent. Anticancer Drugs (2014) 0.75
Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease. Coron Artery Dis (2009) 0.75
"Defragmenting" the noninvasive diagnosis of nonalcoholic steatohepatitis: hopes from cytokeratin-18. Hepatology (2009) 0.75
Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol (2015) 0.75
Familial Mediterranean Fever coexisting with celiac disease: is there a link with long-term colchicine treatment? J Gastrointestin Liver Dis (2009) 0.75